Search

everythinglearnresearchcommunity

for

Search:↓

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Scalp psoriasis treatments like strong corticosteroids and vitamin D3 analogues are effective, especially when combined.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

Personalized, multidisciplinary care improves skin condition management and patient outcomes.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The document explains different types of skin lesions and their characteristics, causes, and related conditions.

The most common skin diseases found were contact dermatitis, scabies, fungal infections, urticaria, and acne, highlighting the need for better public health policies and awareness.

Hair care products are important for appearance and self-esteem, and choosing the right ones can help maintain healthy hair.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Transplant patients often get skin problems, with treatments varying by condition.

The study found that many young Syrian refugees have skin infections, especially cutaneous leishmaniasis, and need better health care and living conditions.

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.